Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Khloris Biosciences logo — Pioneering medical treatment using advanced stem cell techno...

Khloris Biosciences

Pioneering medical treatment using advanced stem cell technology to address critical cardiovascular and other diseases with significant unmet needs.

Founded 2017 Venture round Total: $5.00M Biotechnology, Life Sciences +1

General Information

Company Name Khloris Biosciences
Founded Year 2017
Founders / Decision Makers
Team member Team member
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Khloris Biosciences. To contact Khloris Biosciences, visit khlorisbiosciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Khloris Biosciences

Khloris Biosciences is a biotechnology startup based in the Bay Area that was established in 2017. The company is dedicated to advancing the treatment of cardiovascular and other diseases with significant unmet needs. Their groundbreaking approach involves using disease-specific induced pluripotent stem cells (iPSCs) for pioneering drug screening and discovery. With a focus on biotechnology, life sciences, and pharmaceutical industries, Khloris Biosciences aims to address critical medical conditions through advanced stem cell technology. The company recently secured a noteworthy $5.00M Venture Round investment on 06 December 2018. This funding serves as a testament to investor confidence in their innovative approach and the potential impact of their technology. Although the specific investors behind this round are not disclosed, this substantial investment underscores the potential that Khloris Biosciences holds in revolutionizing medical treatments through stem cell technology.

Taxonomy: Stem Cell Technology, Cardiovascular Diseases, Drug Screening, Induced Pluripotent Stem Cells, Medical Innovation, Bay Area, Biomedical Research, Disease-Specific Treatment, Unmet Medical Needs, Innovative Therapies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $5.00M -
06 Dec 2018

Khloris Biosciences Alternatives & Competitors

Khloris Biosciences vs
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. United States

Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS...

Series C
128 employees
Biotechnology, Health and Wellness
Khloris Biosciences vs
Cellular Engineering Technologies
Cellular Engineering Technologies

Innovative biopharmaceutical advancements shaping patient therapy for a healthier future.

Seed
2-10 employees
Biotechnology, Pharmaceutical
Khloris Biosciences vs
APstem Therapeutics
APstem Therapeutics United States

An unprecedented era of stem cell therapy has arrived!

Seed
7 employees
Biotechnology, Health Care
Compare Khloris Biosciences vs APstem Therapeutics

FAQ About Khloris Biosciences

Pioneering medical treatment using advanced stem cell technology to address critical cardiovascular and other diseases with significant unmet needs.
Khloris Biosciences was founded in 2017.
Khloris Biosciences operates in Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Stem Cell Technology, Cardiovascular Diseases, Drug Screening and Induced Pluripotent Stem Cells.
Khloris Biosciences has completed 1 funding round, raising a total of $5.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Khloris Biosciences include Aspen Neuroscience, Inc., Cellular Engineering Technologies, APstem Therapeutics, Vastera, Yuanyin Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Khloris Biosciences and Aspen Neuroscience, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Khloris Biosciences, https://bouncewatch.com/company/khloris-biosciences, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes